Advertisement

Topics

Michelson Diagnostics Ltd Company Profile

02:53 EST 20th November 2017 | BioPortfolio

Michelson Diagnostics Ltd is the UK's leading independent manufacturer and developer of Optical Coherence Tomography medical imaging equipment. Founded in 2006, it is based in SE London, UK.


News Articles [505 Associated News Articles listed on BioPortfolio]

Global and Asia Dermatology Diagnostics Devices Market Status and Future Forecast 20132023 [Report Updated: 08112017] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Co-Diagnostics, Synbiotics launch joint venture CoSara Diagnostics in India

Co-Diagnostics, a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic tests, officially announced the recent incorporation of CoSara Diagnostics, a ...

IPO nets $6.4mm for Co-Diagnostics

Molecular diagnostics start-up Co-Diagnostics Inc. netted $6.4mm through its initial public offering of 1.18mm common shares at $6 each on the Nasdaq.

Global Dermatology Diagnostics Devices Market Research Report 20112023 [Report Updated: 04112017] Prices from USD $2780

SummaryThe global Dermatology Diagnostics Devices market will reach xxx Million USD in 2017 with CAGR xx% 20182023. The objective of report is to define, segment, and project the market on the basis o...

Ortho Clinical Diagnostics and EKF Diagnostics Collaborate for Assay

Ortho Clinical Diagnostics and EKF Diagnostics have entered into an agreement that allows Ortho customers to access the Beta-Hydroxybutyrate (BHB)...

EKF Diagnostics and Ortho Clinical Diagnostics collaborate on a new diabetic ketoacidosis assay

Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, and EKF Diagnostics (EKF) today announced an agreement that allows Ortho customers to access to Beta-Hydroxybutyrate (BHB) ...

Thermo Fisher: Market Shares and Competitive Position by Product and CountryPerformance, Capabilities, Goals and Strategies in the Global Diagnostics Industry [Report Updated: 24082017] Prices from USD $4250

This unique market intelligence report from LeadingMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates b...

Diabetic Ketoacidosis Assay Collaboration Between Ortho Clinical Diagnostics And EKF diagnostic GmbH

RARITAN, N.J. and CARDIFF, Wales, Oct. 11, 2017 /PRNewswire/ --Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, and EKF Diagnostics (EKF) today announced an agreement that ...

Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]

Oxygen

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [222 Associated PubMed Articles listed on BioPortfolio]

Component resolved diagnostics for hymenoptera venom allergy.

Component-resolved diagnostics makes use of defined allergen molecules to analyse IgE-mediated sensitizations at a molecular level. Here, we review recent studies on the use of component-resolved diag...

Comprehensive genetic study of cystic fibrosis in Slovak patients in 25 years of genetic diagnostics.

Cystic fibrosis (CF) has one of the longest histories in hereditary disease molecular diagnostics. However, identification of causative mutations in the CFTR gene is complicated by over two thousand c...

Advances in point-of-care technologies for molecular diagnostics.

Advances in miniaturization, nanotechnology, and microfluidics, along with developments in cloud-connected point-of-care (POC) diagnostics technologies are pushing the frontiers of POC devices toward ...

Local enamel demineralization diagnostics and treatment.

The article describes focal enamel demineralization - the most common disease of teeth hard tissues. Local and general factors of this pathological process advent and development were described. The m...

Molecular diagnostics of ALK-positive lung cancer.

ALK translocation is the 3rd most frequent genetic aberration in lung adenocarcinoma, and several inhibitors are now clinically available in first and second line settings. Accordingly, molecular diag...

Clinical Trials [163 Associated Clinical Trials listed on BioPortfolio]

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

The purpose of this study is to assess the performance of the HTLV Blot 2.4 from patients with the following conditions: infected with HTLV and neurological conditions with symptoms simila...

HIV Point-of-Care Test Evaluation in Infants

HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, T...

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of ...

Companies [899 Associated Companies listed on BioPortfolio]

Michelson Diagnostics Ltd

Michelson Diagnostics Ltd is the UK's leading independent manufacturer and developer of Optical Coherence Tomography medical imaging equipment. Founded in 2006, it is based in SE London, UK.

The Michelson Found Animals Foundation

Michelson Found Animals is an independently funded non-profit foundation led by business, animal welfare, and medical professionals who develop innovative solutions that address t...

Michelson Found Animals Foundation

The Michelson Found Animals Foundation is a non-profit supporting pet-owners and animal welfare organizations; our mission is Saving Pets, Enriching Lives. After celebrating a dec...

Lein Applied Diagnostics

Lein Applied Diagnostics' goal is to develop non-invasive glucose meters to allow people with diabetes to test their blood glucose levels.Diabetes has an enormous impact on individuals and on society ...

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

More Information about "Michelson Diagnostics Ltd" on BioPortfolio

We have published hundreds of Michelson Diagnostics Ltd news stories on BioPortfolio along with dozens of Michelson Diagnostics Ltd Clinical Trials and PubMed Articles about Michelson Diagnostics Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Michelson Diagnostics Ltd Companies in our database. You can also find out about relevant Michelson Diagnostics Ltd Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record